AAAAAA

   
Results: 1-11 |
Results: 11
ALENDRONATE CO-MEDICATIONS MAY LIMIT ITS USE
Authors: LEVINE MAH GROOTENDORST P
Citation: Mah. Levine et P. Grootendorst, ALENDRONATE CO-MEDICATIONS MAY LIMIT ITS USE, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 97-97
INTRAPATIENT VARIABILITY IN RESPONSE TO NSAID THERAPY FOR RHEUMATOID-ARTHRITIS
Authors: DOLOVICH LR LEVINE MAH GOLDSMITH CH
Citation: Lr. Dolovich et al., INTRAPATIENT VARIABILITY IN RESPONSE TO NSAID THERAPY FOR RHEUMATOID-ARTHRITIS, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 126-126
A PROSPECTIVE COMPARISON OF 4 STUDY DESIGNS USED IN ASSESSING SAFETY AND EFFECTIVENESS OF DRUG-THERAPY IN HYPERTENSION MANAGEMENT
Authors: LEVINE MAH HAMET P NOVOSEL S JOLAIN B
Citation: Mah. Levine et al., A PROSPECTIVE COMPARISON OF 4 STUDY DESIGNS USED IN ASSESSING SAFETY AND EFFECTIVENESS OF DRUG-THERAPY IN HYPERTENSION MANAGEMENT, American journal of hypertension, 10(11), 1997, pp. 1191-1200
COST-BENEFIT ANALYSES IN THE HEALTH-CARE LITERATURE - DONT JUDGE A STUDY BY ITS LABEL
Authors: ZARNKE KB LEVINE MAH OBRIEN BJ
Citation: Kb. Zarnke et al., COST-BENEFIT ANALYSES IN THE HEALTH-CARE LITERATURE - DONT JUDGE A STUDY BY ITS LABEL, Journal of clinical epidemiology, 50(7), 1997, pp. 813-822
DEVELOPING A CANADIAN PRESCRIBING PRACTICES NETWORK
Authors: HOLBROOK AM MACLEOD SM FISHER P LEVINE MAH
Citation: Am. Holbrook et al., DEVELOPING A CANADIAN PRESCRIBING PRACTICES NETWORK, CMAJ. Canadian Medical Association journal, 154(9), 1996, pp. 1325-1331
TREATMENT OF CHRONIC ATRIAL-FIBRILLATION WITH WARFARIN OR ASPIRIN - ACOST-EFFECTIVENESS AND COST-UTILITY ANALYSIS
Authors: ZARNKE KB LEVINE MAH OBRIEN B
Citation: Kb. Zarnke et al., TREATMENT OF CHRONIC ATRIAL-FIBRILLATION WITH WARFARIN OR ASPIRIN - ACOST-EFFECTIVENESS AND COST-UTILITY ANALYSIS, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 89-89
DRUG PRICE AWARENESS SURVEY OF ONTARIO PHYSICIANS
Authors: LEVINE MAH MILLAR A
Citation: Mah. Levine et A. Millar, DRUG PRICE AWARENESS SURVEY OF ONTARIO PHYSICIANS, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 90-90
EXPERIENCE IN THE DEVELOPMENT OF A POSTMARKETING SURVEILLANCE NETWORK- THE PHARMACY MEDICATION MONITORING PROGRAM
Authors: WILLISON DJ GAEBEL KA BORDEN EK LEVINE MAH POSTON JW GOLDSMITH CH WONG B
Citation: Dj. Willison et al., EXPERIENCE IN THE DEVELOPMENT OF A POSTMARKETING SURVEILLANCE NETWORK- THE PHARMACY MEDICATION MONITORING PROGRAM, The Annals of pharmacotherapy, 29(12), 1995, pp. 1208-1213
HEALTH-RELATED QUALITY-OF-LIFE IN PATIENTS WITH MAJOR DEPRESSION WHO ARE TREATED WITH MOCLOBEMIDE
Authors: WALKER V STREINER DL NOVOSEL S ROCCHI A LEVINE MAH DEAN DM
Citation: V. Walker et al., HEALTH-RELATED QUALITY-OF-LIFE IN PATIENTS WITH MAJOR DEPRESSION WHO ARE TREATED WITH MOCLOBEMIDE, Journal of clinical psychopharmacology, 15(4), 1995, pp. 60-67
RCT OF POSTMARKETING SURVEILLANCE METHODS
Authors: LEVINE MAH HAMET P NOVOSEL S JOLAIN B
Citation: Mah. Levine et al., RCT OF POSTMARKETING SURVEILLANCE METHODS, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 147-147
EFFECT OF A POLICY TO REDUCE PHYSICIAN PRESCRIBING OF SUSTAINED-RELEASE (SR) NSAID FORMULATIONS
Authors: LEVINE MAH GAEBEL K GOLDSMITH C BORDEN K POSTEN J WILLISON D
Citation: Mah. Levine et al., EFFECT OF A POLICY TO REDUCE PHYSICIAN PRESCRIBING OF SUSTAINED-RELEASE (SR) NSAID FORMULATIONS, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 147-147
Risultati: 1-11 |